Related Experiment Video
Updated: Aug 13, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1
E C Busby1, D F Leistritz, R T Abraham
1Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
Abstract:
The investigational anticancer agent 7-hydroxystaurosporine (UCN-01) abrogates the G2 checkpoint in tumor cells and sensitizes them to the lethal effects of genotoxic anticancer agents. On the basis of the role of the Cdc25C phosphatase in maintenance of this damage-inducible checkpoint, we hypothesized that UCN-01 inhibits a component of the signal transduction pathway that modulates Cdc25C phosphorylation. Of the three kinases known to phosphorylate Cdc25C on Ser216, both checkpoint kinase 1 (hChk1) and Cdc25C-associated protein kinase 1 (cTAK1) were potently inhibited by UCN-01 with IC50s of 11 and 27 nM, respectively. Treatment of K562 erythroblastoid leukemia cells with similar drug concentrations resulted in decreased levels of Ser216 phosphorylation of Cdc25C and complete disruption of the y-radiation-induced G2 checkpoint. In contrast to hChk1, the hChk2 kinase was 100-fold more resistant to inhibition by UCN-01 (IC50, 1040 nM). These results suggest that disruption of the DNA damage-induced G2 checkpoint by UCN-01 is mediated through the inhibition of the Cdc25C kinases, hChk1 and cTAK1, and that hChk2 activity is not sufficient to enforce the G2 checkpoint in cells treated with a pharmacological inhibitor of hChk1.
Insights
The anticancer agent 7-hydroxystaurosporine (UCN-01) disrupts the G2 checkpoint in tumor cells by inhibiting Cdc25C kinases, specifically checkpoint kinase 1 (hChk1) and cTAK1, enhancing genotoxic drug sensitivity.
Area of Science:
- Oncology
- Cell Cycle Regulation
- Molecular Biology
Background:
- The G2 checkpoint prevents cell division after DNA damage, crucial for preventing mutations.
- Cdc25C phosphatase activity is vital for G2 checkpoint maintenance.
- Investigational anticancer agents like UCN-01 show potential in sensitizing tumors to genotoxic therapies.
Purpose of the Study:
- To investigate the mechanism by which UCN-01 abrogates the G2 checkpoint.
- To determine if UCN-01 targets specific kinases involved in Cdc25C phosphorylation.
- To understand the role of hChk1 and hChk2 in UCN-01-mediated G2 checkpoint abrogation.
Main Methods:
- In vitro kinase assays to determine UCN-01 inhibition of hChk1, cTAK1, and hChk2.
- Treatment of K562 cells with UCN-01 and subsequent analysis of Cdc25C phosphorylation at Ser216.
- Assessment of the G2 checkpoint response to gamma-radiation in UCN-01-treated cells.
Main Results:
- UCN-01 potently inhibited hChk1 (IC50 = 11 nM) and cTAK1 (IC50 = 27 nM).
- UCN-01 treatment decreased Ser216 phosphorylation of Cdc25C and disrupted the gamma-radiation-induced G2 checkpoint in K562 cells.
- hChk2 kinase was significantly less sensitive to UCN-01 inhibition (IC50 = 1040 nM).
Conclusions:
- UCN-01 disrupts the DNA damage-induced G2 checkpoint primarily through the inhibition of hChk1 and cTAK1.
- hChk1 and cTAK1 are key mediators of the G2 checkpoint targeted by UCN-01.
- hChk2 activity alone is insufficient to maintain the G2 checkpoint when hChk1 is pharmacologically inhibited by UCN-01.
Related Concept Videos
Nucleotide Excision Repair
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
DNA Damage Can Stall the Cell Cycle

